Don't Ignore The Insider Selling In Akero Therapeutics - simplywall.st
3 days ago • Google News
Akero Therapeutics Inc (AKRO)
US$ 44.6599-0.27%
Price Chart
Key Statistics
Market Cap
$ 4.44B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
537.19K
52W High
$ 58.40
52W Low
$ 21.02
Dividend Yield
0.00%
Beta
-0.16
Technicals
50-Day MA
44.441
200-Day MA
37.289
52 Week High
58.4
52 Week Low
21.02
About AKRO
Akero Therapeutics, Inc. engages in the development of treatments for patients with serious metabolic diseases in the United States.
Employees
69
Headquarters
South San Francisco, CA
CEO
Dr. Andrew Cheng M.D., Ph.D.
Latest News
Akero Therapeutics (NASDAQ:AKRO) Stock Price Down 3.3% - What's Next? - MarketBeat
Yesterday • Google News
Akero Therapeutics (AKRO) Emerges as Attractive Acquisition Targ - GuruFocus
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg